Approved for 1 INDICATIONS AND USAGE QULIPTA is indicated for the preventive treatment of migraine in adults. QULIPTA is a calcitonin gene-related peptide receptor antagonist indicated for the preventive treatment of migraine in adults. ( 1 ). 12.1 Mechanism of Action Atogepant is a calcitonin gene-related peptide (CGRP) receptor antagonist. Side effects, costs, interactions, manufacturer, and…
Loading full data from Know Your Drugs Institute…